NASDAQ: ZIMVZimvie Inc Stock
$9.67+0.08 (+0.83%)
Updated Sep 22, 2023
ZIMV Price
$9.67
Fair Value Price
N/A
Market Cap
$256.54M
52 Week Low
$5.05
52 Week High
$15.50
P/E
-3.06x
P/B
0.35x
P/S
0.33x
PEG
N/A
Dividend Yield
N/A
Revenue
$894.02M
Earnings
-$82.85M
Gross Margin
68.7%
Operating Margin
-8.51%
Profit Margin
-9.3%
Debt to Equity
1.14
Operating Cash Flow
-$13M
Beta
1.33
Next Earnings
Nov 7, 2023
Ex-Dividend
N/A
Next Dividend
N/A
ZIMV Overview
ZimVie Incorporated develops and manufactures products and solutions to treat a range of spine pathologies and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic products, surgical instrumentation; bone grafts, barrier membrane ,allograft, and collagen wound care products; intraoral scanners; CAD/CAM workflow systems; and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures. The company also provides MIS solutions and motion preservation solutions. ZimVie Inc. was founded in 2021 and is headquartered in Westminster, CO.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZIMV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZIMV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZIMV is good value based on its book value relative to its share price (0.35x), compared to the US Medical Devices industry average (3.54x)
P/B vs Industry Valuation
ZIMV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ZIMV due diligence checks available for Premium users.
Be the first to know about important ZIMV news, forecast changes, insider trades & much more!
ZIMV News
Valuation
ZIMV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.06x
Industry
49.22x
Market
14.52x
ZIMV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.35x
Industry
3.54x
ZIMV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZIMV's financial health
Profit margin
Revenue
$224.9M
Net Income
-$23.4M
Profit Margin
-10.4%
ZIMV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ZIMV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.6B
Liabilities
$832.7M
Debt to equity
1.14
ZIMV's short-term assets ($507.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZIMV's long-term liabilities ($642.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZIMV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$256.0k
Investing
-$1.3M
Financing
$1.2M
ZIMV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ZIMV vs Medical Device Stocks
Zimvie Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.